U.S. News & World Report Ranks HP&M as Top Tier FDA Law Firm for 2017 - 7th Year in a Row!

HP&M's FDA Law Blog once again chosen as an ABA Journal's Blawg 100.

Recent FDA Law Blog Entries from www.fdalawblog.net

Public Citizen Suit Highlights FDA’s Delays in Updating OTC Drug Monographs

CDRH Issues Final Guidance Regarding Interoperable Medical Devices

FDA to Hold Meeting on Home Collection of Pap Smears: Possible Broader Implications?

Fifth Circuit Upholds Summary Judgment for Solvay Pharmaceuticals in Off-Label and Anti-Kickback FCA Case

Articles and Presentations

The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials  July 27, 2017

Congress Seeks a Statutory Fix to Stymied Off-Label Discussions  May 2, 2017

DOJ Uses False Claims Act to Enforce FDA Manufacturing Rules  April 7, 2017

LDTs: The Saga Continues  April 2017

The Problem of the ‘Intended Use’ Regulations Continues to Fester  March 21, 2017

more articles...